DENVER, Nov. 28, 2018 (GLOBE NEWSWIRE) — Dixie Brands, Inc. (“USA Inc.”) and Academy Explorations Limited (“Academy”) are pleased to announce that further to their respective news releases dated October 1, 2018, the companies have completed a reverse takeover (“RTO”) transaction.
Pursuant to the RTO transaction, Academy’s wholly owned subsidiary (“Amalco”) merged with USA Inc., forming a Delaware-incorporated operating company named Dixie Brands (USA) Inc. (“OpCo”).
Through this amalgamation, OpCo became a wholly owned subsidiary of Academy, which is a reporting issuer in Ontario. As part of the RTO, Academy changed its name to Dixie Brands Inc. (“Dixie”) and its officers and directors have resigned effective as of the RTO. New officers and directors were appointed as further detailed in the listing statement.
Former shareholders of USA Inc. were issued a total of 118,137,967 subordinate voting shares of Dixie. Academy shareholders retained 6,640,301 subordinate voting shares of Dixie, after giving effect to a 4-for-1 share consolidation approved by its shareholders earlier this year. Dixie currently has 124,778,269 subordinate voting shares issued and outstanding, as well as 500,000 non-participating voting shares held by Dixie Brands SPV, LLC, a company controlled by certain members of Dixie’s senior management entitling it to 100 votes per non-participating voting share at any Dixie shareholder meeting.
Dixie also announced today that its subordinate voting shares are expected to begin trading on the Canadian Securities Exchange (the “CSE”) under the symbol DIXI.U on November 29, 2018. A listing statement with information about Dixie and prepared in accordance with the policies of the CSE has been filed on SEDAR and is available at www.sedar.com.
Dixie is currently operating in four states (Colorado, California, Nevada, and Maryland) and has international distribution and manufacturing partners in Australia and Canada. Dixie plans to expand into four to six additional states in 2019 through partnerships with licensed and regulated producers in each state.
Already the owner of the largest award-winning, THC-infused product line in the industry, Dixie has recently expanded its hemp-based offerings by introducing Aceso Wellness, a human dietary supplement line, and Therabis, a pet food supplement portfolio, at the end of 2016. These highly regarded products are available through brick-and-mortar locations and e-commerce in all 50 states, and internationally.
On October 1, 2018, Dixie closed its Series C fundraising round of approximately US$25 million. The Series C round was originally offered as a non-brokered private placement for US$20 million. Due to positive investor demand, Dixie increased the maximum offering amount to US$25 million with board and shareholder approval. As a result of the capital raised through the Series C financing and future access to capital in the public markets, Dixie will expand its controlled manufacturing and distribution footprint throughout the U.S. and invest in automated production to increase manufacturing scale and efficiency. Additionally, Dixie will invest in continued product innovation and development in line with mainstream consumer trends and ever-increasing demand from wide-ranging demographics.
To find out more about Dixie’s innovative products, or about how Dixie is building the future of cannabis, please visit us at dixiebrands.com.
About Dixie Brands Inc.
Dixie Brands Inc., which has been formulating award-winning THC and CBD-infused products since 2009, is expecting to double its manufacturing and distribution capabilities in 2019 in the US as well as expand internationally, including Canada. They lead the global industry in the development, packaging design, product innovation and quality control for the commercial production of cannabis infused products. While the company started with a single flagship product, the Dixie Elixir (a THC-infused soda), it is now one of the industry’s most recognized consumer brands, expanding to over 100 products across more than 13 different product categories representing the industry’s finest edibles, tinctures, topicals and connoisseur grade extractions, as well as world-class CBD-infused wellness products and pet dietary supplements. Dixie’s executive team has been instrumental in the formation of the marijuana industry for recreational and medicinal use, serving as founding members on several national regulatory and business-oriented industry organizations. To find out more about Dixie’s innovative products, or about how Dixie is building the future of cannabis, visit www.dixiebrands.com.